Cysteine- Rich Secretory Protein 3 (CRISP3), ERG and PTEN Define a Molecular Subtype of Prostate Cancer With Implication to Patients’ Prognosis

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/1756-8722-7-21
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

TMPRSS2:ETV4Gene Fusions Define a Third Molecular Subtype of Prostate Cancer

Cancer Research
Cancer ResearchOncology
2006English

Association of Cysteine-Rich Secretory Protein 3 and -Microseminoprotein With Outcome After Radical Prostatectomy

Clinical Cancer Research
Cancer ResearchOncology
2007English

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer

Journal of the National Cancer Institute
Cancer ResearchOncology
2015English

Absence of TMPRSS2:ERG Fusions and PTEN Losses in Prostate Cancer Is Associated With a Favorable Outcome

Modern Pathology
Forensic MedicinePathology
2008English

Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Brain Metastases in Patients With Metastatic Breast Cancer : Prognosis According to Subtype

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2017English

Systematic Analysis Reveals Molecular Characteristics of ERG-negative Prostate Cancer

Scientific Reports
Multidisciplinary
2018English

TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers With a Favorable Prognosis

Clinical Cancer Research
Cancer ResearchOncology
2008English

ERG Rearrangement and Protein Expression in the Progression to Castration-Resistant Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy